搜索临床试验以:多西紫杉醇
总计2207个结果
-
Hallym University Medical CenterSanofi; Asan Medical Center完全的
-
Peking University People's Hospital招聘中
-
Shanghai Jiao Tong University School of MedicineShanghai 10th People's Hospital; Jiangxi Provincial Cancer Hospital; Shanghai Tongji Hospital,... 和其他合作者招聘中
-
Asan Medical Center完全的
-
University of Southern CaliforniaSanofi完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Abramson Cancer Center of the University of PennsylvaniaSanofi; Bayer完全的
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.; Aventis Pharmaceuticals完全的
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology完全的
-
Meir Medical Center完全的
-
University of TurkuTurku University Hospital; Sanofi; Vaasa Central Hospital, Vaasa, Finland; medbase Oy Ltd完全的CYP3A 表型分析 | CYP3A5 和 MDR1 基因分型 | 多西他赛毒性 | 遗传数据与多西紫杉醇毒性之间的关联芬兰
-
Ascenta Therapeutics完全的
-
Jonsson Comprehensive Cancer CenterAventis Pharmaceuticals; Genentec完全的
-
Cancer Research Group - Collaborative Group, Beirut...未知
-
Cancer Institute and Hospital, Chinese Academy...Biotech Pharmaceutical Co., Ltd.未知
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals完全的
-
SCRI Development Innovations, LLCSanofi; Genentech, Inc.完全的
-
King Faisal Specialist Hospital & Research Center未知
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Jiangsu ShengDiYa Medicine Co., Ltd.Dongguan People's Hospital未知肺非鳞状非小细胞肿瘤
-
Yale UniversityNational Cancer Institute (NCI)完全的
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Binghe XuHoffmann-La Roche未知
-
Masonic Cancer Center, University of MinnesotaSanofi完全的
-
Mirati Therapeutics Inc.终止
-
National Cancer Institute (NCI)完全的复发性前列腺癌 | 未明确的成人实体瘤,特定方案 | IIIA期非小细胞肺癌 | IIIB 期非小细胞肺癌 | III期前列腺癌 | IV 期前列腺癌 | 复发性非小细胞肺癌 | IV 期非小细胞肺癌加拿大
-
Danish Breast Cancer Cooperative GroupSanofi; Hoffmann-La Roche未知